/PODD
PODD Stock - Insulet Corporation
Healthcare|Medical - DevicesNASDAQ
$278.17-0.14%
$0.38 (-0.14%) • Jan 13
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.23
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.64
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+36.2%upside
Target: $378.87
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PODD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$275.39 – $280.95
TARGET (TP)$378.86
STOP LOSS$255.92
RISK/REWARD1:4.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.40
52W High$354.88
52W Low$230.05
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.07B | $1.70B | $1.31B | $1.10B | $904.40M |
| Gross Profit | $1.45B | $1.16B | $805.60M | $752.10M | $582.30M |
| Gross Margin | 69.8% | 68.3% | 61.7% | 68.4% | 64.4% |
| Operating Income | $308.90M | $220.00M | $37.60M | $126.00M | $51.50M |
| Net Income | $418.30M | $206.30M | $4.60M | $16.80M | $6.80M |
| Net Margin | 20.2% | 12.2% | 0.4% | 1.5% | 0.8% |
| EPS | $5.97 | $2.96 | $0.07 | $0.25 | $0.11 |
Company Overview
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PODDBeat Rate
78%
Last 18 quarters
Avg Surprise
+44.6%
EPS vs Estimate
Beats / Misses
14/4
Last 12 quarters
Latest EPS
$1.24
Q4 2025
EPS Surprise History
Q1 24
+112.1%
$1.40vs$0.66
Q2 24
+87.2%
$0.73vs$0.39
Q3 24
-2.5%
$0.55vs$0.56
Q4 24
+18.4%
$0.90vs$0.76
Q1 25
+15.0%
$1.15vs$1.00
Q2 25
+29.1%
$1.02vs$0.79
Q3 25
+27.2%
$1.17vs$0.92
Q4 25
+8.8%
$1.24vs$1.14
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 19, 2026 | $1.48 | — | — | — |
Q4 2025 | Nov 6, 2025 | $1.14 | $1.24 | +8.8% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.92 | $1.17 | +27.2% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $0.79 | $1.02 | +29.1% | ✓ BEAT |
Q1 2025 | Feb 20, 2025 | $1.00 | $1.15 | +15.0% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $0.76 | $0.90 | +18.4% | ✓ BEAT |
Q3 2024 | Aug 8, 2024 | $0.56 | $0.55 | -2.5% | ✗ MISS |
Q2 2024 | May 9, 2024 | $0.39 | $0.73 | +87.2% | ✓ BEAT |
Q1 2024 | Feb 22, 2024 | $0.66 | $1.40 | +112.1% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $0.40 | $0.71 | +77.5% | ✓ BEAT |
Q3 2023 | Aug 8, 2023 | $0.26 | $0.38 | +46.2% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.09 | $0.23 | +155.6% | ✓ BEAT |
Q1 2023 | Feb 23, 2023 | $0.24 | $0.55 | +129.2% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $0.17 | $0.45 | +164.7% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $0.21 | $-0.06 | -128.6% | ✗ MISS |
Q2 2022 | May 5, 2022 | $0.23 | $0.40 | +73.9% | ✓ BEAT |
Q1 2022 | Feb 23, 2022 | $0.32 | $0.42 | +31.2% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $0.24 | $0.18 | -25.0% | ✗ MISS |
Q3 2021 | Aug 5, 2021 | $0.12 | $0.10 | -16.7% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about PODD
What is PODD's current stock price?
Insulet Corporation (PODD) is currently trading at $278.17 per share. The stock has moved -0.14% today.
What is the analyst price target for PODD?
The average analyst price target for PODD is $378.86, based on 1 analyst.
What sector is Insulet Corporation in?
Insulet Corporation operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is PODD's market cap?
Insulet Corporation has a market capitalization of $19.57 billion, making it a large-cap company.
Does PODD pay dividends?
No, Insulet Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBIIB
Biogen Inc.
$178.30
Mkt Cap: $26.2B
DGX
Quest Diagnostics Incorporated
$179.96
Mkt Cap: $20.1B
DXCM
DexCom, Inc.
$70.25
Mkt Cap: $27.5B
LH
Labcorp Holdings Inc.
$253.98
Mkt Cap: $21.1B
PHG
Koninklijke Philips N.V.
$29.63
Mkt Cap: $28.2B
SNN
Smith & Nephew plc
$31.90
Mkt Cap: $13.9B
STE
STERIS plc
$259.87
Mkt Cap: $25.6B
WAT
Waters Corporation
$394.03
Mkt Cap: $23.5B
WST
West Pharmaceutical Services, Inc.
$271.83
Mkt Cap: $19.6B
ZBH
Zimmer Biomet Holdings, Inc.
$88.34
Mkt Cap: $17.5B
Explore stocks similar to PODD for comparison